
Sign up to save your podcasts
Or


As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.
By JAMA Network4.3
106106 ratings
As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.

503 Listeners

163 Listeners

38 Listeners

21 Listeners

15 Listeners

11 Listeners

8 Listeners

17 Listeners

19 Listeners

5 Listeners

6 Listeners

31 Listeners

9 Listeners

93 Listeners

14 Listeners

5 Listeners

5 Listeners

18 Listeners

2 Listeners